Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company's biggest challenge: how to better tap into America's mass market for weight-loss drugs. https://www.japantimes.co.jp/business/2025/10/22/companies/novo-nordisk-board-us-consumers/?utm_medium=Social&utm_source=mastodon #business #companies #wegovy #pharmaceuticals #novonordisk

Chinese companies are racing to make generic versions of popular branded weight-loss drugs after regulators restricted sale of cheap copies, slowing demand for raw ingredients the firms supplied over the past two years. https://www.japantimes.co.jp/business/2025/09/03/companies/chinese-companies-generics-us-weight/?utm_medium=Social&utm_source=mastodon #business #companies #china #pharmaceuticals #wegovy #elililly#novonordisk #fda